396 Overcoming resistance to anti-PD-1 with tumor agnostic NBTXR3: from bench to bed side

• Ping Zhang,
• Juliette Thariat,
• Tanguy Seiwert,
• Maria Angelica Cortez,
• Jiaxin Niu,
• Colette Shen,
• Jessica Frakes,
• Jared Weiss,
• Jimmy Caudell,
• Hu Yun,
• Sylvie Bonvalot,
• Zsusanna Papaï,
• Katherine Jameson,
• Patricia Said

Affiliations

Ping Zhang

1 Department of Immunology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia

Juliette Thariat

Radiation oncology department, Centre de Lutte Contre le Cancer, Centre Francois Baclesse, Caen, France

Tanguy Seiwert

Aff247 grid.170205.10000000419367822University of Chicago, Chicago Chicago IL USA

Maria Angelica Cortez

2 Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Jiaxin Niu

7Banner MD Anderson Cancer Center, Gilbert, AZ, USA

Colette Shen

2University of North Carolina, Chapel Hill, NC, USA

Jessica Frakes

3Moffitt Cancer Center, Tampa, USA

Jared Weiss

2University of North Carolina, Chapel Hill, NC, USA

Jimmy Caudell

3Moffitt Cancer Center, Tampa, USA

Hu Yun

5MD Anderson Cancer Center, Houston, TX, USA

Sylvie Bonvalot

7Institut Curie, Paris, Cedex 05, France

Zsusanna Papaï

8MH Egeszsegugyi Kozpont, Hungarian Defe, Budapest, Hungary

Katherine Jameson

10Nanobiotix, corp, Cambridge, MA, USA

Patricia Said

9Nanobiotix, SA, Paris, France